September 18th, 2026Centanafadine For Comorbid ADHD and Anxiety: Talking New Data With John Kraus, MD, PhDPhase 3b data show centanafadine reduces adult ADHD and comorbid anxiety.Read more
September 9th, 2026New Phase 3 Data on Oveporexton for Narcolepsy Type 1Phase 3 NEJM data show oveporexton improves wakefulness, reduces cataplexy, and boosts quality of life in narcolepsy type 1, with manageable adverse effects.Read more
September 9th, 2026Choosing Sexual Function-Sparing MedicationsLearn why SSRIs impair sex and how bupropion, PDE5 inhibitors, buspirone, and newer agents can prevent or reverse antidepressant sexual side effects.Read more
September 8th, 2026Anita Clayton, MD, on Diagnosing and Discussing Sexual DysfunctionExperts unpack screening for sexual dysfunction in psychiatric care, menopause and meds impacts, and when flibanserin may help restore desire.Read more